If the TSX doesnt approve the exemption and there is a "remedial delisting", 

how likely / how soon would it be relisted? 

How would the RVXCF (US board) stock be affected? 

Would that delist too? Would a separate application for exemption be required there, or would it automatically follow the TSX?

The market seems not to like the news, big drop, but then, big dilution too. 

Still seems like essentially good news - covering that huge debt, but I guess the market doesn't agree.

Wish they could find more venture capital investors based in US, Canada. 

Not to dis Hepalink. Just would be nice to have a more diverse foundation of financial backing.